Exploring how Ubiquitin-Specific Proteases (USPs) drive cancer drug resistance and the promising therapeutic strategies targeting these molecular scissors.
Exploring the cellular mechanisms behind proteasome inhibitor resistance in multiple myeloma and emerging strategies to overcome this challenge in cancer treatment.
Explore how proteasomal subunits are revolutionizing cancer therapy through targeted inhibition and overcoming drug resistance in various cancers.
Exploring how CRISPR genome-wide screens reveal myeloma's drug resistance mechanisms to degronimid therapies and proteasome inhibitors.